Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Clinical Chemistry

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/49.8.1279PMID 12881443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy

  2002cited by this paper
• Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy

  2002cited by this paper
• Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly

  2002cited by this paper
• Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.

  2002cited by this paper
• Phenotypic diversity in hypertrophic cardiomyopathy.

  2002cited by this paper
• Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive Physiology

  2002cited by this paper
• Mutations of the Light Meromyosin Domain of the &bgr;-Myosin Heavy Chain Rod in Hypertrophic Cardiomyopathy

  2002cited by this paper
• Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.

  2001cited by this paper
• The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age.

  2001cited by this paper
• Low sequence variation in the gene encoding the human beta-myosin heavy chain.

  2001cited by this paper
• The molecular genetic basis for hypertrophic cardiomyopathy.

  2001cited by this paper
• Low Sequence Variation in the Gene Encoding the Human β-Myosin Heavy Chain

  2001cited by this paper
• A Novel Missense Mutation, Leu390Val, in the Cardiac ß-myosin Heavy Chain Associated with Pronounced Septal Hypertrophy in Two Families with Hypertrophic Cardiomyopathy

  2000cited by this paper
• A novel missense mutation, Leu390Val, in the cardiac beta-myosin heavy chain associated with pronounced septal hypertrophy in two families with hypertrophic cardiomyopathy.

  2000cited by this paper
• Functional consequences of a carboxyl terminal missense mutation Arg278Cys in human cardiac troponin T.

  1999cited by this paper
• Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes.

  1998cited by this paper
• Molecular Genetic Basis of Hypertrophic Cardiomyopathy:

  1998cited by this paper
• The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.

  1998cited by this paper
• Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function.

  1998cited by this paper
• Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.

  1998cited by this paper
• A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes

  1998cited by this paper
• Sudden death due to troponin T mutations.

  1997cited by this paper
• Familial hypertrophic cardiomyopathy: diagnostic and therapeutic implications of recent genetic studies.

  1996cited by this paper
• Clinical manifestations of hypertrophic cardiomyopathy with mutations in the cardiac beta-myosin heavy chain gene or cardiac troponin T gene.

  1996cited by this paper
• Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the Cardia Study

  1996cited by this paper
• Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

  1995cited by this paper
• Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

  1995cited by this paper
• Recent advances in the molecular genetics of hypertrophic cardiomyopathy.

  1995cited by this paper
• Molecular basis of familial cardiomyopathies.

  1995cited by this paper
• Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

  1994cited by this paper
• Differences in Clinical Expression of Hypertrophic Cardiomyopathy Associated With Two Distinct Mutations in the β‐Myosin Heavy Chain Gene: A 908Leu→Val Mutation and a 403Arg→gGln Mutation

  1992cited by this paper
• Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations.

  1992cited by this paper
• Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

  1992cited by this paper
• A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

  1990cited by this paper
• Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

  1989cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography.

  1984cited by this paper

• Correlations of gene polymorphisms of angiotensin-converting enzyme 2 with onset and prognosis of hypertrophic cardiomyopathy

  2025cites this paper
• Genetic predisposition in chemotherapy‐induced cardiomyopathy in a 65‐year‐old female with metastatic breast cancer

  2024cites this paper
• MYH7 in cardiomyopathy and skeletal muscle myopathy

  2023cites this paper
• Case report: A new de novo mutation of the Troponin T2 gene in a Chinese patient with dilated cardiomyopathy

  2023cites this paper
• Dynamical Behavior of Disordered Regions in Disease-Related Proteins Revealed by Quasielastic Neutron Scattering

  2022cites this paper
• Genetic predisposition study of heart failure and its association with cardiomyopathy

  2022cites this paper
• Genetic investigations of 100 inherited cardiac disease-related genes in deceased individuals with schizophrenia

  2021cites this paper
• Intrinsically Conductive Polymers for Striated Cardiac Muscle Repair

  2021cites this paper
• A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy

  2020cites this paper
• Rapid diagnostic testing of a neonate in a family with hypertrophic cardiomyopathy

  2020cites this paper
• Crossbridge Recruitment Capacity of Wild-Type and Hypertrophic Cardiomyopathy-Related Mutant Troponin-T Evaluated by X-ray Diffraction and Mechanical Study of Cardiac Skinned Fibers

  2020cites this paper
• Effects of troponin cardiomyopathy mutations on the calcium binding properties of the troponin complex and reconstituted thin filaments

  2019cites this paper
• Single Nucleotide Polymorphisms in Sarcomeric Protein Genes: Association with Chemotherapy Induced Cardiomyopathy

  2018cites this paper
• Impact of Variant Reclassification in the Clinical Setting of Cardiovascular Genetics

  2017cites this paper
• Genetic Misdiagnoses and the Potential for Health Disparities.

  2016cites this paper
• TNNT2 Gene Polymorphisms are Associated with Susceptibility to Idiopathic Dilated Cardiomyopathy in Kazak and Han Chinese

  2015cites this paper
• Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing.

  2014cites this paper
• Cardiac Troponin T (TNNT2) Mutations in Chinese Dilated Cardiomyopathy Patients

  2014cites this paper
• Study of a Colombian Family with Hypertrophic Cardiomyopathy and Sudden Cardiac Death Associated with the Lys247arg Mutation in the Cardiac Troponin T (Tnnt2) Gene: Casual Relationship or Polymorphism?

  2014cites this paper
• INVESTIGATION OF MUTATIONS IN EXONS 12-15 MYH7 GENE IN HYPERTROPHIC CARDIOMYOPATHIE PATIENTS USING PCR-SSCP TECHNIQUE

  2013cites this paper
• TNNT2 Gene Polymorphisms Are Associated with Susceptibility to Idiopathic Dilated Cardiomyopathy in the Han Chinese Population

  2013influential citation
• The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain).

  2013cites this paper
• Genetic variation screening of TNNT2 gene in a cohort of patients with hypertrophic and dilated cardiomyopathy.

  2012cites this paper
• Long-Term Outcomes in Hypertrophic Cardiomyopathy Caused by Mutations in the Cardiac Troponin T Gene

  2012cites this paper
• Consequences of Mutations in Genes Encoding Cardiac Troponin C, T and I – Molecular Insights

  2012influential citation
• Resequencing the whole MYH7 gene (including the intronic, promoter, and 3' UTR sequences) in hypertrophic cardiomyopathy.

  2012cites this paper
• Challenges associated with clinical studies and the integration of gene expression data

  2012influential citation
• Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population.

  2012cites this paper
• Genetic heterogeneity for autosomal dominant familial hypertrophic cardiomyopathy in a Pakistani family.

  2011cites this paper
• Analysis of the Micro‐RNA‐133 and PITX3 genes in Parkinson's disease

  2010cites this paper
• Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil

  2010cites this paper
• Open Access RESEARCH

  2010cites this paper
• Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.

  2010cites this paper
• Genetic basis of hypertrophic cardiomyopathy

  2010cites this paper
• Examination of FGFRL1 as a candidate gene for diaphragmatic defects at chromosome 4p16.3 shows that Fgfrl1 null mice have reduced expression of Tpm3, sarcomere genes and Lrtm1 in the diaphragm

  2010cites this paper
• Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?

  2010cites this paper
• Single Nucleotide Polymorphisms in Sarcomeric Protein Genes: Association withChemotherapy Induced Cardiomyopathy

  2010cites this paper
• Estudo de mutações Causadoras de Cardiomiopatia Hipertrófica em um Grupo de Pacientes no Espírito Santo, Brasil Study of Mutations Causing Hypertrophic Cardiomyopathy in a Group of Patients from Espirito Santo, Brazil

  2010cites this paper
• [Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil].

  2010cites this paper
• Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy

  2009cites this paper
• Miocardiopatía hipertrófica. Estudio del gen de la troponina T en 127 familias españolas

  2009cites this paper
• Multiple Mutations in Genetic Cardiovascular Disease: A Marker of Disease Severity?

  2009cites this paper
• The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy

  2009cites this paper
• Espectro mutacional de los genes sarcoméricos MYH7, MYBPC3, TNNT2, TNNI3 y TPM1 en pacientes con miocardiopatía hipertrófica

  2009cites this paper
• Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

  2009cites this paper
• [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].

  2009cites this paper
• Clinical and Functional Characterization of TNNT2 Mutations Identified in Patients With Dilated Cardiomyopathy

  2009cites this paper
• Hypertrophic cardiomyopathy. A study of the troponin-T gene in 127 Spanish families.

  2009cites this paper
• Mitochondrial Transcription Factor A (TFAM) Gene Variation and Risk of Late-Onset Alzheimer's Disease

  2008cites this paper
• A search for cyclophilin‐A gene (PPIA) variation and its contribution to the risk of atherosclerosis and myocardial infarction

  2008cites this paper
• Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.

  2008cites this paper
• Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy.

  2008cites this paper
• Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy.

  2007cites this paper
• Prevalence and spectrum of mutations in the sarcomeric troponin T and I genes in a cohort of Spanish cardiac hypertrophy patients.

  2007cites this paper
• From the crystal structure of troponin to the mechanism of calcium regulation of muscle contraction.

  2007cites this paper
• Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy.

  2006cites this paper
• Mutaciones en el gen de la cadena pesada de la betamiosina en pacientes con miocardiopatía hipertrófica

  2006cites this paper
• Miocardiopatía hipertrófica: la complejidad que no cesa

  2006cites this paper
• Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts – role of myofilament Ca2+ sensitivity increase

  2006cites this paper
• Genetic basis of hypertrophic cardiomyopathy

  2006cites this paper
• [Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].

  2006cites this paper
• Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.

  2006cites this paper
• Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?

  2005cites this paper
• F110I and R278C Troponin T Mutations That Cause Familial Hypertrophic Cardiomyopathy Affect Muscle Contraction in Transgenic Mice and Reconstituted Human Cardiac Fibers*

  2005cites this paper
• Sarcomeric genotyping in hypertrophic cardiomyopathy.

  2005cites this paper
• Yield of genetic testing in hypertrophic cardiomyopathy.

  2005cites this paper
• Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect.

  2005cites this paper
• Cardiac troponin T mutations in Chinese patients with hypertrophic cardiomyopathy.

  2004cites this paper
• Molecular and Cellular Aspects of Troponin Cardiomyopathies

  2004cites this paper
• Inherited Cardiomyopathies as a Troponin Disease

  2004cites this paper
• Proteomics and cancer diagnosis: the potential of mass spectrometry.

  2004cites this paper
• Miocardiopatía hipertrófica: ¿cómo predecir su evolución?

  2004cites this paper
• A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction

  2004cites this paper
• Miocardiopatía hipertrófica. Bases genéticas e implicaciones clínicas

  2004cites this paper
• [Hypertrophic myocardiopathy: how to predict its evolution?].

  2004cites this paper
• Inherited cardiomyopathies as a troponin disease.

  2004cites this paper
• Role of troponin T in disease

  2004cites this paper